Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid Cancer

CONTEXT: Five to 10% of patients with differentiated thyroid cancers (DTC) develop invasive and/or distant metastatic disease that is marginally improved with standard therapies. Prognosis is poor for patients with anaplastic thyroid cancer, with a median survival of 3–5 months. We suggest that a pa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Endocrinol Metab
Main Authors: Bastman, Jill J., Serracino, Hilary S., Zhu, Yuwen, Koenig, Michelle R., Mateescu, Valerica, Sams, Sharon B., Davies, Kurtis D., Raeburn, Christopher D., McIntyre, Robert C., Haugen, Bryan R., French, Jena D.
Formato: Artigo
Idioma:Inglês
Publicado em: Endocrine Society 2016
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4929840/
https://ncbi.nlm.nih.gov/pubmed/27045886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2015-4227
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados